DIP pre-payment and provider behavior mechanism. by Chenxuan Zhu (22622476)

“…</p><p>Results</p><p>From January 2019 to June 2023, total costs for surgical and non-surgical groups decreased by 3.42% and 1.25%, respectively. Drug and surgical costs declined significantly (p < 0.05) in both groups, while consumable costs increased significantly (p < 0.05). …”

Annual average incidence rates of human rabies in provinces from 2004–2020. by Weiwei Meng (304234)

Representative Western blots for proteins from specific gene groups, nitric oxide production, and NETs formation. by Daniel R. Ambruso (12042605)

Neutrophil function assays completed on CGD patients off and after the 4^th dose of IFN-γ. by Daniel R. Ambruso (12042605)

“…Bactericidal Activity</b> was determined against <i><i>S. aureus</i></i> with 1:1 ratio of neutrophils to bacteria in 10% normal human serum by standard colony count technique, and results were represented as % viable bacteria at various times over the 2-hour incubation period. …”

NMP and PLU inhibit efflux activity in <i>Mycobacterium abscessus</i>. by Timilehin Faboro (20175963)

Neutrophil Superoxide anion production, Heat map for gene expression from neutrophils of CGD patients, and PCA plot for genome-wide gene expression. by Daniel R. Ambruso (12042605)

“…Heat map</b> showing changes for all significant genes between off IFN-γ and 10-12 hours after the 1st and 4th dose (50 µg/m²) of the cytokine given on a routine schedule noted in Methods. …”

Volitional control frequency and intensity in VH (Kapsner-Smith et al., 2025) by Mara R. Kapsner-Smith (22139315)

“…</p><p dir="ltr"><b>Method: </b>Twenty-six people with HVDs and 26 matched controls participated in tasks to assess the smallest volitional increases and decreases they could make in vocal <i>F</i>0 and intensity. …”

Vaccinia virus and VSV infections of <i>STAT1</i> and <i>IRF1</i> KO cells grown in glucose/galactose with and without IFN-γ priming. by Tyron Chang (9922533)

Cinnamaldehyde is a specific ligand for HL-IR. by Ceyan Kuang (8554557)

Flow cytometry measurement of CD11b, F-actin expression and content, and MHC Class II antigen expression of neutrophils from patients with CGD. by Daniel R. Ambruso (12042605)

Ferrofluid droplet generation on a functional wedged surface atθ = 20°, Q = 5 ml h^-‍1 and L = 10 mm. τ = t_breakup -t represents the remaining time until the d... by Amirhossein Favakeh (21417884)

Downregulation of CD36 impaired phagocytic capacity and is associated with a proinflammatory phenotype of <i>Mst1</i> deficiency macrophages. by Jianyang Li (461703)

Experimental design used in broiler chickens. by Oumayma Arbani (21001472)

“…This study demonstrates a clear clinical difference among the two isolates; A/chicken/Morocco/178-2/2022(H9N2) showed a significant increase in virulence compared to the firstly isolate A/chicken/Morocco/SF1/2016(H9N2). …”

The RehaGait® system. by Johanna Rydja (12300797)

“…More research is warranted about how gait speed affects other gait variables in iNPH.</p><p>Trial registration</p><p>ClinicalTrials.gov <a href="https://clinicaltrials.gov/ct2/show/NCT04795089" target="_blank">NCT04795089</a></p></div>…”

Flow chart of included patients and dropouts. by Johanna Rydja (12300797)

“…More research is warranted about how gait speed affects other gait variables in iNPH.</p><p>Trial registration</p><p>ClinicalTrials.gov <a href="https://clinicaltrials.gov/ct2/show/NCT04795089" target="_blank">NCT04795089</a></p></div>…”

Dataset of the analyzed data. by Johanna Rydja (12300797)

“…More research is warranted about how gait speed affects other gait variables in iNPH.</p><p>Trial registration</p><p>ClinicalTrials.gov <a href="https://clinicaltrials.gov/ct2/show/NCT04795089" target="_blank">NCT04795089</a></p></div>…”

Transcriptomics Points-of-Departure (tPODs) to Support Hazard Assessment of Benzo[<i>a</i>]pyrene in Early-Life-Stage Rainbow Trout by Alper James Alcaraz (20977320)

“…Benchmark concentration analysis of transcriptomic responses at 4 dph, based on the most sensitive transcriptomic features, yielded tPODs between 0.028 and 0.47 μg/L B[<i>a</i>]P. At 28 dph, Cyp1a1 exhibited significantly increased catalytic activity, with biochemical POD, bPOD_EROD,28dph of 0.599 μg/L B[<i>a</i>]P, while morphometric analysis showed significant growth inhibition in terms of length, with apical POD, aPOD_length,28dph of 1.77 μg/L B[<i>a</i>]P, with a notable decreasing trend in body weight. …”

Transcriptomics Points-of-Departure (tPODs) to Support Hazard Assessment of Benzo[<i>a</i>]pyrene in Early-Life-Stage Rainbow Trout by Alper James Alcaraz (20977320)

“…Benchmark concentration analysis of transcriptomic responses at 4 dph, based on the most sensitive transcriptomic features, yielded tPODs between 0.028 and 0.47 μg/L B[<i>a</i>]P. At 28 dph, Cyp1a1 exhibited significantly increased catalytic activity, with biochemical POD, bPOD_EROD,28dph of 0.599 μg/L B[<i>a</i>]P, while morphometric analysis showed significant growth inhibition in terms of length, with apical POD, aPOD_length,28dph of 1.77 μg/L B[<i>a</i>]P, with a notable decreasing trend in body weight. …”

Transcriptomics Points-of-Departure (tPODs) to Support Hazard Assessment of Benzo[<i>a</i>]pyrene in Early-Life-Stage Rainbow Trout by Alper James Alcaraz (20977320)

“…Benchmark concentration analysis of transcriptomic responses at 4 dph, based on the most sensitive transcriptomic features, yielded tPODs between 0.028 and 0.47 μg/L B[<i>a</i>]P. At 28 dph, Cyp1a1 exhibited significantly increased catalytic activity, with biochemical POD, bPOD_EROD,28dph of 0.599 μg/L B[<i>a</i>]P, while morphometric analysis showed significant growth inhibition in terms of length, with apical POD, aPOD_length,28dph of 1.77 μg/L B[<i>a</i>]P, with a notable decreasing trend in body weight. …”

Transcriptomics Points-of-Departure (tPODs) to Support Hazard Assessment of Benzo[<i>a</i>]pyrene in Early-Life-Stage Rainbow Trout by Alper James Alcaraz (20977320)

“…Benchmark concentration analysis of transcriptomic responses at 4 dph, based on the most sensitive transcriptomic features, yielded tPODs between 0.028 and 0.47 μg/L B[<i>a</i>]P. At 28 dph, Cyp1a1 exhibited significantly increased catalytic activity, with biochemical POD, bPOD_EROD,28dph of 0.599 μg/L B[<i>a</i>]P, while morphometric analysis showed significant growth inhibition in terms of length, with apical POD, aPOD_length,28dph of 1.77 μg/L B[<i>a</i>]P, with a notable decreasing trend in body weight. …”